High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. (Record no. 29754989)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02106 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518042700.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202005s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1097-0142 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/cncr.32079 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hollis, Robert L |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200518 |
| 245 00 - TITLE STATEMENT | |
| Title | High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer |
| Date of publication, distribution, etc. | 08 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2772-2781 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | BRCA2 Protein |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bevacizumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carboplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cohort Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Computer Simulation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cystadenocarcinoma, Serous |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Proteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nuclear Proteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ovarian Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Paclitaxel |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Repressor Proteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Reproducibility of Results |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Churchman, Michael |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Michie, Caroline O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rye, Tzyvia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Knight, Laura |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McCavigan, Andrena |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perren, Timothy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Williams, Alistair R W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McCluggage, W Glenn |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kaplan, Richard S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jayson, Gordon C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Oza, Amit |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Harkin, D Paul |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Herrington, C Simon |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kennedy, Richard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gourley, Charlie |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer |
| Related parts | vol. 125 |
| -- | no. 16 |
| -- | p. 2772-2781 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/cncr.32079">https://doi.org/10.1002/cncr.32079</a> |
| Public note | Available from publisher's website |
No items available.